Format

Send to

Choose Destination
Anaerobe. 2016 Aug;40:50-3. doi: 10.1016/j.anaerobe.2016.05.004. Epub 2016 May 7.

Screening for enterotoxigenic Bacteroides fragilis in stool samples.

Author information

1
Department of Surgery, University of Otago Christchurch, Christchurch, New Zealand. Electronic address: jacqui.keenan@otago.ac.nz.
2
Department of Surgery, University of Otago Christchurch, Christchurch, New Zealand.
3
Microbiology Department, Canterbury Health Laboratories, Christchurch, New Zealand.
4
Biostatistics and Computational Biology Unit, University of Otago Christchurch, Christchurch, New Zealand.

Abstract

Bacteroides fragilis is a commensal bacterium found in the gut of most humans, however enterotoxigenic B. fragilis strains (ETBF) have been associated with diarrhoea and colorectal cancer (CRC). The purpose of this study was to establish a method of screening for the Bacteroides fragilis toxin (bft) gene in stool samples, as a means of determining if carriage of ETBF is detected more often in CRC patients than in age-matched healthy controls. Stool samples from 71 patients recently diagnosed with CRC, and 71 age-matched controls, were screened by standard and quantitative PCR using primers specific for the detection of the bft gene. Bacterial template DNA from stool samples was prepared by two methods: a sweep, where all colonies growing on Bacteroides Bile Esculin agar following stool culture for 48 h at 37 °C in an anaerobic environment were swept into sterile water and heat treated; and a direct DNA extraction from each stool sample. The bft gene was detected more frequently from DNA isolated from bacterial sweeps than from matched direct DNA extractions. qPCR was found to be more sensitive than standard PCR in detecting bft. The cumulative total of positive qPCR assays from both sample types revealed that 19 of the CRC patients had evidence of the toxin gene in their stool sample (27%), compared to seven of the age-matched controls (10%). This difference was significant (P = 0.016). Overall, ETBF carriage was detected more often in CRC patient stool samples compared to controls, but disparate findings from the different DNA preparations and testing methods suggests that poor sensitivity may limit molecular detection of ETBF in stool samples.

KEYWORDS:

Colorectal cancer; Enterotoxigenic Bacteroides fragilis; PCR; Stool samples; bft gene

PMID:
27166180
DOI:
10.1016/j.anaerobe.2016.05.004
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center